Indefinite Delivery Contract N0018925DZ006

Award Date 1/30/25
Last Date to Order 1/29/30
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal Indefinite Delivery Contract (IDC) was awarded by the Navy Bureau of Medicine and Surgery, a defense agency, to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation. The $323,566.47 single-award IDC has an ultimate completion date of October 31, 2029 and is for the delivery of DRI Hydrocodone Reagent Kits, 500ML. Microgenics is a key supplier for the Department of Defense Drug Demand Reduction Program, providing a wide range of immunoassay...
The Department of Veterans Affairs, through its Veterans Integrated Service Network 23 (VISN 23), has awarded an indefinite delivery contract (IDC) to Microgenics Corporation, a manufacturer of clinical diagnostic products, for the supply of toxicology reagents. The $852,120.80 single-award IDC has an ultimate completion date of September 30, 2029 and is not set aside for any particular business category. Under this IDC, Microgenics has received a $770,593.60 firm-fixed price delivery order...
Microgenics Corporation, a subsidiary of Thermo Electron Corporation, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of the Navy Bureau of Medicine and Surgery for the supply of DRI opiate reagent test kits in support of the DOD Drug Demand Reduction Program. The $750,435.30 IDC has a ceiling value and allows for the issuance of firm-fixed price delivery orders over a 5-year period of performance through May 2028. Microgenics has received multiple task orders...
The Department of Defense (DoD) has awarded Microgenics Corporation, a subsidiary of Thermo Electron Corporation, an indefinite delivery contract (IDC) worth up to $5,515,434.90 to provide benzodiazepine immunoassay reagent kits and related laboratory supplies in support of the DoD Drug Demand Reduction Program (DDRP). This single-award IDC has a period of performance through April 30, 2028 and does not utilize any set-aside designations. Under this IDC, Microgenics has received numerous...
The Indefinite Delivery Contract (IDC) award N0018925DZ009 was made by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Alere San Diego, Inc. (a subsidiary of Abbott Laboratories) to provide 6-AM reagent kits for use with Beckman Coulter AU5800 series clinical chemistry analyzers. The $750,102.21 single-award IDC has a period of performance through January 2030 and aims to support the Department of Defense's Drug Demand Reduction Program with up to...
The U.S. Department of the Navy's Bureau of Medicine and Surgery has awarded a single-award, indefinite delivery contract (IDC) to Microgenics Corporation's Clinical Diagnostics Division for the procurement of MDMA/MDA reagent kits. The $1,154,822.40 contract has a performance period from March 2024 to March 2029. This IDC will provide the Department of Defense Drug Demand Reduction Program with a variety of immunoassay reagent test kits and related laboratory supplies to support substance...
The Indefinite Delivery Contract (IDC) N0018923D0042 was awarded by the Department of the Navy Bureau of Medicine and Surgery (BUMED) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract has a ceiling value of $4,407,148.40 and a period of performance through September 28, 2026. Under the IDC, Roche was awarded a $1,000,742.33 firm fixed price delivery order...
This Indefinite Delivery Contract (IDC) with the ID N6264515D5052 was awarded by the Bureau of Medicine and Surgery, a Defense agency, to Biomerieux Inc. through its Biomerieux, Inc. Division. The contract, which does not involve any set-asides, has a ceiling value of $279,600 and was originally awarded on October 1, 2015, with a final completion date of September 30, 2020. The primary purpose of this IDC is to procure CPRR-Automated Blood Culture Analyzer and CPRR-Automated Microbiology...
This Indefinite Delivery Contract (IDC) ID W9124D06A0001 was awarded by the U.S. Department of the Army to Instant Technologies, Inc., a subsidiary of Alere Inc., to provide drug test kits. The single-award IDC has a ceiling value of $1,000,000.00 and a period of performance from November 1, 2005 to October 31, 2008. Under this IDC, a Delivery Order (DO) W9124D06A0001|1E01 was issued on September 28, 2006 with a ceiling value of $4,968.00 and a period of performance through September 30,...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) awarded a single-award Indefinite Delivery Contract (IDC) to Microgenics Corporation, the Clinical Diagnostics Division of Thermo Electron Corporation, to provide drugs of abuse analyzers, reagents, and controls in support of substance abuse testing and treatment programs at VA medical facilities. The $895,686 IDC has a period of performance through December 7, 2024 and does not include any set-aside...
  • N0018925DZ006
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Indefinite Delivery Contract (IDC) N0018925DZ006 was awarded to Microgenics Corporation, a manufacturer of clinical diagnostic products and toxicology testing solutions. The $775,453.50 single-award contract was issued by the Navy Bureau of Medicine and Surgery, a defense agency, with a period of performance through January 2030.

The purpose of this IDC is to provide the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems with a steady supply of FDA-approved diagnostic reagent kits and laboratory equipment used for substance abuse testing and treatment programs. The contract covers a range of reagents capable of detecting controlled substances such as opiates, benzodiazepines, hydrocodone, MDMA/MDA, and oxycodone. This supports the DoD Drug Demand Reduction Program by equipping military and veteran medical facilities with the necessary tools for clinical toxicology screenings. The IDC serves as a primary source of these specialized diagnostic products for the Navy Bureau of Medicine and Surgery, Defense Health Agency, and various VA Integrated Service Networks.

Generated 4/30/25, 9:59 AM